Introduction
Hematopoietic stem cells (HSCs) comprise a rare population of cells residing in the bone marrow (BM). They have the unique capability to maintain a balance between quiescence, self-renewal, and proliferation/differentiation into multiple blood lineages. This dynamic equilibrium is essential for preserving stem cells pool throughout the life of the organism, while constantly supplying blood cells at the steady-state and under stress conditions such as infection or bleeding. Cell intrinsic regulation of signal transduction, cell cycle progression and gene expression, as well as extrinsic factors from the microenvironment have been implicated in regulating HSC self-renewal vs. differentiation decisions. Importantly, quiescence is required to preserve HSC stemness and their long-term reconstitution ability. However, intrinsic mechanisms that regulate HSC homeostasis and cell cycle state to promote stemness remain incompletely understood.
Cytokines signaling through their cognate receptors play important roles in hematopoiesis. One such signaling axis is thrombopoietin (Tpo) and its receptor, Mpl. Tpo is the primary cytokine that regulates megakaryocyte development and platelet production [1] [2] [3] . Tpo activates Mpl in HSCs to maintain HSC quiescence and self-renewal 4, 5 and Mpl -/-or Tpo -/-mice exhibit reduced HSC numbers and self-renewal capability [6] [7] [8] [9] . Furthermore, Mpl loss-of-function mutations are responsible for congenital amegakaryocytic thrombocytopenia (CAMT) and progressive BM failure 10 . These findings established a critical role for Tpo/Mpl signaling in HSC development and functions in mice and humans.
Tpo binding to Mpl activates Janus Kinase 2 (JAK2), triggering a cascade of signaling events, involving Stat5, PI3K/Akt, and p44/42MAPK 1, 11 . JAK2-deficient hematopoietic cells fail to respond to Tpo and an array of hematopoietic cytokines, revealing JAK2's essential role in cytokine receptor signaling 12 . Others and we have previously shown that the adaptor protein Lnk (also called
For personal use only. on October 31, 2017 . by guest www.bloodjournal.org From SH2B3) negatively regulates the Tpo/Mpl/JAK2 pathway [13] [14] [15] . Lnk -/-mice harbor a markedly expanded HSC pool, with superior reconstitution ability due to an increase in HSC self-renewal 13, 16 .
The effects of Lnk in HSCs are negated upon deletion of Mpl 13 , further cementing the role of the Tpo/Mpl/JAK2 signaling axis in regulating HSC cell cycle and self-renewal.
To delineate mechanisms for Lnk function, we previously used a proteomic strategy to identify Lnk-interacting proteins 17 . This approach revealed a novel interaction between Lnk and a deubiquitinating enzyme (DUB) complex, BRISC 17 . The BRISC DUB complex specifically hydrolyzes lysine 63 -ubiquitin (K63-Ub) conjugates, a non-degradative form of Ub that has been implicated in hematopoiesis and cytokine receptor signaling [18] [19] [20] . There are 8 different possible linkages for ubiquitin chains. K48-Ub is the canonical form that targets proteins for degradation through the proteasome 21 . In contrast, K63-Ub does not target proteins to the proteasome, but rather, mediates various biological processes, including DNA repair 22, 23 , protein trafficking 24 , autophagy 25 , and signal transduction 26 . An in vivo role of K63-Ub in early stages of hematopoiesis has been previously suggested based on the observation that the loss of Ubc13 (the Ub-conjugating enzyme specific for K63-Ub chains) in mice leads to hematopoietic failure owing to loss of HSCs and progenitors (HSPCs) 27 . However, how K63-Ub affects hematopoiesis or HSC function has not been well established.
BRISC was first biochemically purified as a major K63-DUB activity in the cytoplasm 28 . The BRISC complex has recently been implicated in inflammatory cytokine signaling 20 ; however a role for BRISC in hematopoiesis has not been reported. BRISC is composed of the enzyme BRCC36
and three core complex constituents (KIAA0157, MERIT40, and BRCC45) 18, 19 . MERIT40
(Mediator of RAP80 Interactions and Targeting 40 kD, also called BABAM1) is the scaffold protein critical for the complex stability and DUB activity 22, 29, 30 . The Lnk-BRISC interaction
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Our studies revealed a novel contribution of MERIT40 to stem cell homeostasis, thus suggesting an unappreciated role for nondegradative deubiquitination in regulating stem cell function. 
Methods

Animals
Flow cytometric analysis of HSPC subsets
The staining procedure was performed as previously described 13, 31, 32 . Briefly, for HSPC subset BM cells were first stained with biotinylated-lineage cocktail that contains anti-CD4, CD8, CD5, Ter119, Gr-1, Mac-1, B220, CD19 and IL-7R antibodies (eBiosciences), followed by streptavidinPhycoerythrin (PE)-TexasRed secondary antibodies (Caltag, Invitrogen) and PE-Cy5.5-conjugated anti-Sca-1, APC-Alexa750-Kit, APC-CD34, and PE-Flk2 (eBiosciences) antibodies. For SLAM markers, PE-Cy7-CD150 and Fluorescein isothiocyanate (FITC)-CD48 antibodies (Biolegend)
were used. Cells were subsequently collected on Fortessa flow cytometer (BD Biosciences) and data was analyzed using FlowJo software. F1 recipient mice. Sixteen weeks after injection, percent donor-derived cells in peripheral blood was determined by flow cytometry as previously described 13 . Mice with donor-derived cells in the blood higher than 1% were counted as "positive reconstitution". Data from 3-5 independent experiments were combined and competitive repopulation units were calculated using L-Calc software (Stem Cells Technologies, Vancouver, Canada).
BMT of purified HSCs
Fluorescence-activated cell sorting (FACS) of HSCs for BMT was performed as previously described 33 . and injected into lethally irradiated F1 recipients. The percent of chimerism in peripheral blood was assessed by flow cytometry 16 weeks after BMT. Primary transplanted mice were sacrificed at 4 months, and 3000 donor LSK cells were purified and transplanted into lethally irradiated secondary recipients along with competitor cells. Cells from each primary recipient were injected into one to four secondary recipients.
5-FU assay
WT and M40 -/-mice were injected intraperitoneally with 150mg/kg 5-Fluorouracil (5-FU) once a week for the indicated time and moribund animals euthanized according to the protocol. 
Microarray and reverse transcription-quantitative PCR (RT-qPCR)
Purified CD150 + CD48 -LSK HSCs from WT and M40 -/-mice were sorted directly into Trizol LS (Invitrogen). RNA was isolated using microRNeasy kit (QIAGEN), and the microarray analysis was performed at the PENN Molecular Profiling⁄Genomics Facility using GeneChip Mouse Gene 2.0ST
array (Affymetrix, Santa Clara, CA). Resulting expression data were normalized using robust multichip analysis (RMA) directly from the CEL files. Significant differential expression between the two groups was analyzed, and genes with SAM P values <0.05 were selected. Microarray data have been deposited at the Gene Expression Omnibus, accession number GSE65245. Microarray data were also tested for gene set enrichment analysis (GSEA) using MSigDb c2.cp v3.0 34 .
5'-Bromodeoxyuridine (BrdU) and Pyronin/Hoechst staining
WT and M40 -/-mice were injected with BrdU for 2 hours or fed with BrdU (0.5 mg/ml) in drinking water for 7 days before analysis. Total BM cells were isolated and Lin -ckit + cells were sorted using Aria. Cells were then stained with ckit-APC-Cy7, Sca1-PE, CD48-FITC, CD150-PE-Cy7, and BrdU-APC antibodies following manufacturer's instructions (BD Biosciences, San Diego, CA).
Cells were resuspended in buffer containing DAPI for flow cytometry. Sorted SLAM LSK cells were incubated with 5μg/ml of Hoechst 33342 (Molecular Probes) in Hank's Balanced Salt Solution containing 20mM HEPES, 5mM Glucose, and 10% FBS at 37°C for 45 minutes, followed by an additional 45 minutes incubation with 1μg/ml of Pyronin Y (Sigma). Cells were subsequently analyzed on Fortessa flow cytometer (BD Biosciences).
Western blot (WB) analysis
LSK cells from WT and M40 -/-mice were starved for 2h in RPMI medium (Invitrogen) supplemented with 0.5% BSA and stimulated with 1 or 10ng/ml mouse recombinant Tpo 
Results
Loss of MERIT40 expands HSC pool
We previously found that the BRCC36-containing DUB complex BRISC associates with Lnk 17 , which is an important negative regulator of Tpo/Mpl-mediated signaling in HSCs 13 . To determine if this interaction is involved in cytokine-signaling in hematopoiesis, we generated mice deficient in M40, the scaffold protein that is critical for the integrity of this DUB complex 22 .
mice showed complete loss of M40 expression at both mRNA and protein levels (Fig. 1S ). As predicted, protein levels of BRCC36 were markedly reduced in the BM from M40 -/-mice (Supplemental Fig.1S ), in agreement with our published studies showing that M40 plays a scaffolding and stability function for the M40-BRCC36 containing DUB complexes 22 . To functionally quantify HSC frequency and assess whether M40 affects HSC reconstitution potential, we employed competitive limiting dilution bone marrow transplantation (BMT). The results revealed that M40 -/-mice indeed harbored increased numbers of functional HSCs (Fig. 1B) .
M40
Importantly, M40 -/-BM cells gave rise to greater donor chimerism in all blood lineages in the recipient mice ( Fig. 1C and 1D ), suggesting that M40 -/-BMs have superior long term repopulating abilities. Of note, M40 deficiency did not affect HSPC homing efficiency (Fig. 4S) . Hence, our data strongly support that M40 deficiency leads to an expansion of phenotypic and functional HSC pool.
Enhanced repopulating and self-renewal ability of Merit40 -/-HSCs
We transplanted purified HSCs to investigate if the increase in repopulation observed in M40 -/-transplanted animals is due to intrinsic HSC properties rather than that of the committed Fig. S5 ), and increased survival upon repetitive 5-FU administration (Fig. 3A) . One day after 5-FU treatment,
M40
-/-mice showed increased clonogenic survival in comparison to WT mice (Fig. 3B) HSCs upon cytotoxic stress at day 7 ( Fig. 3C ) with increased cell proliferation as determined by BrdU incorporation assays (Fig. 3D) . After two injections of 5-FU, WT mice showed marked hypoplastic BM with progenitor cell numbers being substantially lower than those of M40 -/-mice ( Fig. 3E) , which explains the prolonged survival due to loss of M40. Collectively, these data suggest that M40 deficiency protects HSPCs from cytotoxic stress and promotes HSC regeneration.
Decelerated cell cycle and increased quiescence in Merit40 -/-HSCs
The proper control of HSC quiescence and cell proliferation/differentiation is critical for HSC maintenance and self-renewal ability. We thus examined HSC cell cycle kinetics using BrdU incorporation assays. In both long term (7 days) and short term (2 hours) BrdU labeling, M40
-/-SLAM LSKs had a marked decrease in the BrdU + population compared to WT HSCs (Fig. 4A ). 40 . Consistent with our BrdU experiment,
M40
-/-HSCs exhibited a larger G0 population than WT HSCs (Fig. 4B) . Together, our data suggest that loss of M40 slows the cell cycle and acquire HSC quiescence.
To investigate the molecular mechanisms by which M40 regulates HSC cell cycle, we performed genome-wide transcriptome analysis using sorted SLAM LSKs from WT and M40 -/-mice. Gene Set Enrichment analysis (GSEA) 34 revealed and RT-qPCR confirmed that M40 -/-HSCs showed downregulation in gene sets associated with cell cycle, mitosis, DNA replication pathways (Fig. 4C,   4D and Supplemental Table 1S ). Furthermore, the top 5 most significantly downregulated GeneOntology (GO) terms in the Biological Process (BP) in M40 -/-HSCs were associated with cell division (Supplemental Table 2S ). Thus, the gene expression signature is consistent with a role for M40 in controlling HSC cell cycle. 
Hyperactivation of Tpo signaling in Merit40 -/-HSPCs
MERIT40 functions in HSCs are mediated through the Tpo/Mpl pathway
Mice deficient for M40 harbor elevated numbers of LT-HSCs and circulating platelets, both of which depend on Mpl signaling triggered by Tpo. Therefore, our finding of increased sensitivity to We found that both Lnk and M40 act through the Tpo/Mpl pathway, attesting to the importance of Tpo/mpl in protecting HSC quiescence and promoting self-renewal.
Cytokine signaling is regulated by posttranslational modifications, such as phosphorylation and ubiquitination, to enable rapid transduction of extracellular cues. A role for protein ubiquitination in 60 . Characterization of mouse models with deletion of ubiquitin ligases showed hematopoietic perturbations often caused by failure to target selected proteins for proteosomal degradation 56, [61] [62] [63] and causing dysregulation of the stem cell compartment.
For example, lack of Cbl led to elevated HSPC numbers with increased repopulating activities and augmented proliferation in response to Tpo 64 . Similarly, increased numbers of HSPCs with high proliferative potential were reported in mice deficient in Itch, an E3 ligase for Notch 65 . Furthermore, mice deficient in Fbw7, an E3 ligase for Myc, have functionally impaired HSPC, increased fraction of cycling HSC and decreased expression of genes associated with HSC self-renewal phenotype 57, 66 .
Ubiquitination is a reversible process, as DUBs can rapidly de-conjugate ubiquitinated substrates 67 .
Deletion of Mysm, a DUB for histone H2A, results in loss of HSC quiescence and stem cell exhaustion 68 . These examples illustrate the complex effects of protein ubiquitination on stem cells maintenance and functions.
M40 is essential for the integrity of complexes with K63-DUB activity, suggesting a previously unrecognized role for nondegradative ubiquitination in regulating stem cells activity. Consistent with a role for K63-ubiquitination in protein activity rather than proteosomal degradation, we detected increased phosphorylation of JAK2, STAT5 and Akt but not total protein levels. Increased
Tpo-mediated signaling in M40 -/-HSPCs suggests that component(s) of Tpo/Mpl/JAK2 signaling pathway are likely subjected to regulation by M40-associated DUB activities. Our genetic experiments showed that M40 negatively regulates Mpl signaling, and that M40's effects on HSCs are dependent upon the Mpl pathway. Moreover, our previous biochemical studies showed physical interaction between Lnk, JAK2 and the M40 complex 13, 17 . Together these results are consistent with a role of M40 in the Tpo/Mpl/JAK2/Lnk signaling pathway. We recently reported that one of M40-associated complexes, BRISC, localizes to and deubiquitinates actively engaged interferon receptor, thus limiting its K63-Ub mediated internalization 20 . However, we failed to detect any changes in cell surface expression or endocytosis of the Mpl receptor in M40 null HSPCs (data not shown).
Future investigation is warranted to pinpoint the exact targets of the MERIT40 complex in HSCs.
Allogeneic HSPC transplantation is standard of care for a variety of hematopoietic malignancies and congenital blood diseases 69 . However, a majority of patients remain ineligible for conventional allogeneic HSPC transplantation due to the lack of appropriately matched donors. The use of umbilical cord blood as a source of allogeneic HSPC has expanded the donor pool. However, it is associated with delayed engraftment and failure to engraft. Despite extensive research efforts, the process of stem cell expansion is not fully understood. Cytokine therapy may not only enhance the production of mature hematopoietic cells, but also improve the engraftment and expansion of HSCs.
DUBs are specialized proteases that have emerged as potential "druggable" targets. Thus, our studies might yield novel pharmacologic strategies that could be used for controlled stem cell expansion for transplantation without malignant transformation. In conclusion, this study has identified MERIT40 as a novel HSC regulator, suggesting an unappreciated role for nondegradative deubiquitination in regulating stem cell function.
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